{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:46:10Z","timestamp":1793400370978,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022330","name":"Office of Intramural Training and Education","doi-asserted-by":"publisher","award":["ZIA BC 011345"],"award-info":[{"award-number":["ZIA BC 011345"]}],"id":[{"id":"10.13039\/100022330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022330","name":"Office of Intramural Training and Education","doi-asserted-by":"publisher","award":["ZIA BC 011870"],"award-info":[{"award-number":["ZIA BC 011870"]}],"id":[{"id":"10.13039\/100022330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022330","name":"Office of Intramural Training and Education","doi-asserted-by":"publisher","award":["ZIA BC 011343"],"award-info":[{"award-number":["ZIA BC 011343"]}],"id":[{"id":"10.13039\/100022330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011475","name":"Cholangiocarcinoma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.immuni.2025.02.017","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T10:39:51Z","timestamp":1741948791000},"page":"926-945.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-7067","authenticated-orcid":false,"given":"Mohamed-Reda","family":"Benmebarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Myojin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylynda C.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Villamor-Pay\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodriguez-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlaine","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Trehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Budhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Kedei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Telford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouzeh","family":"Korangy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-2535","authenticated-orcid":false,"given":"Tim F.","family":"Greten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2025.02.017_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bjc.2017.401","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Kitano","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","article-title":"Regulatory T\u00a0cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"127","author":"Konishi","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib4","first-page":"509","article-title":"Immunosuppressive CD29(+) Treg accumulation in the liver in mice on checkpoint inhibitor therapy","volume":"73","author":"Green","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.immuni.2025.02.017_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib6","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in\u00a0vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2025.02.017_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nrclinonc.2018.9","article-title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","volume":"15","author":"Khan","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.immuni.2025.02.017_bib9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6912","article-title":"Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma","volume":"13","author":"Monge","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/2326-6066.CIR-18-0066","article-title":"Treg Fragility: A Prerequisite for Effective Antitumor Immunity?","volume":"6","author":"Overacre-Delgoffe","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2020.11.037","article-title":"CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma","volume":"74","author":"Diggs","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib13","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1016\/j.ajpath.2017.07.022","article-title":"Oncogenic Determination of a Broad Spectrum of Phenotypes of Hepatocyte-Derived Mouse Liver Tumors","volume":"187","author":"Yamamoto","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.immuni.2025.02.017_bib14","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","article-title":"Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2025.02.017_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.02.017_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib17","doi-asserted-by":"crossref","first-page":"e136417","DOI":"10.1172\/jci.insight.136417","article-title":"Effects of B cell\u2013activating factor on tumor immunity","volume":"5","author":"Yarchoan","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2025.02.017_bib18","article-title":"CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer","volume":"9","author":"Yang","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and Its\u00a0Receptor CXCR5 in Cancer: Inflammation, Immune Response, and\u00a0Beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.immuni.2025.02.017_bib20","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","article-title":"Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma","volume":"25","author":"Shu","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nri3464","article-title":"The plasticity and stability of regulatory T\u00a0cells","volume":"13","author":"Sakaguchi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T\u00a0cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2025.02.017_bib23","article-title":"Agonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro-environment","author":"Maltez","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.immuni.2025.02.017_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nm.2389","article-title":"Identification of T helper type 1-like, Foxp3+ regulatory T\u00a0cells in human autoimmune disease","volume":"17","author":"Dominguez-Villar","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib25","article-title":"Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-\u03b3, IL-2 and IL-2R","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.immuni.2025.02.017_bib26","series-title":"Regular and Young Investigator Award Abstracts","first-page":"A1090","article-title":"1048 Interplay of IL-12 and IFNg to induce T reg fragility within the tumor microenvironment","author":"Scott","year":"2022"},{"key":"10.1016\/j.immuni.2025.02.017_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/eji.200939887","article-title":"VEGFR2 is selectively expressed by FOXP3high CD4+ Treg","volume":"40","author":"Suzuki","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib28","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-\u03b3 Drives T(reg) Fragility to Promote Anti-tumor Immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.gde.2015.04.002","article-title":"X-chromosome inactivation: new insights into cis and trans regulation","volume":"31","author":"Galupa","year":"2015","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.immuni.2025.02.017_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gde.2014.09.010","article-title":"X chromosome inactivation: recent advances and a look forward","volume":"28","author":"Briggs","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.immuni.2025.02.017_bib31","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.cell.2013.02.016","article-title":"X-inactivation, imprinting, and long noncoding RNAs in health and disease","volume":"152","author":"Lee","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib32","article-title":"Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy","volume":"8","author":"Chuckran","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03720","article-title":"Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding","volume":"3","author":"Gelfand","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2025.02.017_bib34","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e16158","article-title":"Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma","volume":"41","author":"Monge","year":"2023","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2025.02.017_bib35","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/hep.30482","article-title":"Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer","volume":"69","author":"Xie","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.immuni.2025.02.017_bib36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111769","article-title":"Cancer cell-derived type I interferons instruct tumor monocyte polarization","volume":"41","author":"Kwart","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.02.017_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.02.017_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","article-title":"Precursor exhausted T\u00a0cells: key to successful immunotherapy?","volume":"20","author":"Kallies","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib40","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41591-021-01398-3","article-title":"An ex\u00a0vivo tumor fragment platform to dissect response to PD-1 blockade in cancer","volume":"27","author":"Voabil","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib42","article-title":"The Role of Cytokines in Predicting the Response and Adverse Events Related to Immune Checkpoint Inhibitors","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/cancers13020167","article-title":"IL-12 Family Cytokines in Cancer and Immunotherapy","volume":"13","author":"Mirlekar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.immuni.2025.02.017_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamaophthalmol.2014.5373","article-title":"Serum Levels of Vascular Endothelial Growth Factor and Related Factors After Intravitreous Bevacizumab Injection for Retinopathy of Prematurity","volume":"133","author":"Wu","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.immuni.2025.02.017_bib45","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.4110\/in.2021.21.e23","article-title":"Enriching CCL3 in the Tumor Microenvironment Facilitates T\u00a0cell Responses and Improves the Efficacy of Anti-PD-1 Therapy","volume":"21","author":"Kang","year":"2021","journal-title":"Immune Netw."},{"key":"10.1016\/j.immuni.2025.02.017_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41584-021-00584-4","article-title":"TNF in the era of immune checkpoint inhibitors: friend or foe?","volume":"17","author":"Chen","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib47","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/1078-0432.CCR-15-1655","article-title":"Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18","volume":"22","author":"Ma","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.immuni.2025.02.017_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1215-2","article-title":"Targeting the CBM complex causes T(reg) cells to prime tumours for immune checkpoint therapy","volume":"570","author":"Di Pilato","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.02.017_bib50","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.02.017_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abk0957","article-title":"BATF epigenetically and transcriptionally controls the activation program of regulatory T\u00a0cells in human tumors","volume":"7","author":"Itahashi","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s41590-023-01589-9","article-title":"Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T\u00a0cells","volume":"24","author":"Freuchet","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T\u00a0cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640725","article-title":"TCRMatch: Predicting T-Cell Receptor Specificity Based on Sequence Similarity to Previously Characterized Receptors","volume":"12","author":"Chronister","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.32150","article-title":"The immunogenomic landscape of resected intrahepatic cholangiocarcinoma","volume":"75","author":"Carapeto","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.immuni.2025.02.017_bib56","doi-asserted-by":"crossref","first-page":"24644","DOI":"10.18632\/oncotarget.15602","article-title":"PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma","volume":"8","author":"Fontugne","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.immuni.2025.02.017_bib57","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2019.05.026","article-title":"Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex\u00a0vivo targeting immune checkpoint molecules","volume":"71","author":"Zhou","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2016.08.012","article-title":"Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages","volume":"66","author":"Raggi","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib59","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2025.02.017_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111384","article-title":"Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T\u00a0cell paralysis","volume":"40","author":"Keenan","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.02.017_bib61","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","article-title":"Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin","volume":"186","author":"Ruf","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103375","article-title":"Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target","volume":"67","author":"Zhou","year":"2021","journal-title":"EBiomedicine"},{"key":"10.1016\/j.immuni.2025.02.017_bib63","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","article-title":"Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target","volume":"77","author":"Alvisi","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T\u00a0cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2025.02.017_bib65","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T\u00a0cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.immuni.2025.02.017_bib66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2567.2011.03483.x","article-title":"Helper T-cell differentiation and plasticity: insights from epigenetics","volume":"134","author":"Hirahara","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.immuni.2025.02.017_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102982","article-title":"Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations","volume":"134","author":"Kumar","year":"2023","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.immuni.2025.02.017_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/ni1424","article-title":"Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells","volume":"8","author":"Djuretic","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T\u00a0cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2025.02.017_bib70","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.15252\/embr.201541905","article-title":"AKT isoforms modulate Th1-like Treg generation and function in human autoimmune disease","volume":"17","author":"Kitz","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.immuni.2025.02.017_bib71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.3077","article-title":"Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability","volume":"16","author":"Huynh","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib72","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1182\/blood-2006-07-035279","article-title":"Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells","volume":"109","author":"Crellin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2025.02.017_bib73","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/JLB.2MIR0817-349R","article-title":"The PI3K\/AKT signaling pathway in regulatory T-cell development, stability, and function","volume":"103","author":"Pompura","year":"2018","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.immuni.2025.02.017_bib74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","article-title":"Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities","volume":"22","author":"Laumont","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2025.02.017_bib75","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.canlet.2014.09.026","article-title":"Regulatory B cells accelerate hepatocellular carcinoma progression via CD40\/CD154 signaling pathway","volume":"355","author":"Shao","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.immuni.2025.02.017_bib76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","article-title":"Interaction between tumour-infiltrating B cells and T\u00a0cells controls the progression of hepatocellular carcinoma","volume":"66","author":"Garnelo","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.immuni.2025.02.017_bib77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib78","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1172\/JCI18025","article-title":"BAFF selectively enhances the survival of plasmablasts generated from human memory B cells","volume":"112","author":"Avery","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2025.02.017_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2025.02.017_bib80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.183.1.147","article-title":"The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells","volume":"183","author":"Ma","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.189.1.1","article-title":"Human Non-Germinal Center B Cell Interleukin (IL)-12 Production Is Primarily Regulated by T Cell Signals CD40 Ligand, Interferon \u03b3, and IL-10: Role of B Cells in the Maintenance of \u2009T Cell Responses","volume":"189","author":"Schultze","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2025.02.017_bib82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib83","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T\u00a0cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2025.02.017_bib84","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/2326-6066.CIR-20-0969","article-title":"Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors","volume":"9","author":"Grigoriou","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib85","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41575-018-0033-6","article-title":"Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research","volume":"15","author":"Brown","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.immuni.2025.02.017_bib86","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2025.02.017_bib87","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/gutjnl-2021-325288","article-title":"The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma","volume":"71","author":"Heinrich","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.immuni.2025.02.017_bib88","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2025.02.017_bib89","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2025.02.017_bib90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2025.02.017_bib91","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2025.02.017_bib92","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s42003-020-01625-6","article-title":"Mapping the immune environment in clear cell renal carcinoma by single-cell genomics","volume":"4","author":"Borcherding","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.immuni.2025.02.017_bib93","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"Street","year":"2018","journal-title":"BMC Genomics"},{"key":"10.1016\/j.immuni.2025.02.017_bib94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61737-979-6_2","article-title":"In\u00a0vitro Treg suppression assays","volume":"707","author":"Collison","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2025.02.017_bib95","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","article-title":"propeller: testing for differences in cell type proportions in single cell data","volume":"38","author":"Phipson","year":"2022","journal-title":"Bioinformatics"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761325000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:24:12Z","timestamp":1762363452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761325000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1074761325000846"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2025.02.017","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2025.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}